Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€72.18

€72.18

0.880%
0.63
0.880%
-

-

 
21:25 / Tradegate WKN: 890952 / Symbol: CMXHF / Name: CSL / Stock / Pharmaceuticals / Large Cap /
Your prediction

CSL Ltd Stock

CSL Ltd gained 0.880% compared to yesterday.

Pros and Cons of CSL Ltd in the next few years

Pros
?
C******** o* t** e**********
?
S********** s********
?
B****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of CSL Ltd vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
CSL Ltd 0.880% -4.993% -0.777% -52.217% -27.902% -56.676% -61.059%
Grifols SA -1.300% 3.918% 1.687% -23.529% -15.434% - -
Grifols S.A. 2.940% 5.947% 5.065% -21.410% -12.275% -26.220% -53.812%
IQVIA Holdings Inc. -0.050% 1.498% 11.653% 7.869% -5.230% -12.857% -13.557%

News

Carlisle Companies: A Strong Contender in the Building Products SectorPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Carlisle Companies: A Strong Contender in the Building Products Sector

Explore the exciting world of Carlisle Companies (NYSE: CSL) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into